Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer.

Autor: Kaufman, Bella, Stein, Steven, Casey, Michelle A., Newstat, Beth O.
Zdroj: Biologics: Targets & Therapy; 2008, Vol. 2 Issue 1, p61-65, 5p
Databáze: Complementary Index